IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 4365 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  Navigate here 
  Search
 
   Next article
   Previous article 
   Table of Contents
  
 Resource links
   Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
   [PDF Not available] *
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)  

 
  In this article
    References

 Article Access Statistics
    Viewed3472    
    Printed54    
    Emailed0    
    PDF Downloaded1    
    Comments [Add]    

Recommend this journal

 
LETTER TO EDITOR
Year : 2001  |  Volume : 67  |  Issue : 4  |  Page : 220

Rifampicin monotherapy for acute guttate psoriasis-better avoided


TC 74/220, CRA-21, Kairali Lane, Vallakadavu, Trivandrum 695008, India

Correspondence Address:
TC 74/220, CRA-21, Kairali Lane, Vallakadavu, Trivandrum 695008, India



How to cite this article:
Usha V, Gomathy S. Rifampicin monotherapy for acute guttate psoriasis-better avoided. Indian J Dermatol Venereol Leprol 2001;67:220


How to cite this URL:
Usha V, Gomathy S. Rifampicin monotherapy for acute guttate psoriasis-better avoided. Indian J Dermatol Venereol Leprol [serial online] 2001 [cited 2019 Sep 17];67:220. Available from: http://www.ijdvl.com/text.asp?2001/67/4/220/12402


To the Editor,
I read with great interest, the article published by Qazi Masood et al[1] in the recent issue of the journal. Rifampicin is one of the most effective bactericidal drugs in the treatment of tuberculosis and leprosy.[2]
Streptococcal infection associated with acute guttate psoriasis is sensitive to p lactum antibiotics and other broad spectrum antibiotics.[3]
Unlike with penicillin, many organisms develop early resistance to rifampicin.[4] and in most cases it is a one step mutation.[2]
Therefore, in streptococcal infections and other infections which can be treated by -lactum antibiotics, the use of rifampicin should be restricted, especially as a monotherapy.
Rifampicin should be reserved for tuberculosis, leprosy and other serious infections which are not responsive to the commonly used antibiotics.
Though the clinical response reported is encouraging, such studies with rifampicin as monotherapy are better avoided in the light of current resurgence of mycobacterial infections. 

   References Top

1.Qazi Masood, Manzoor S and Rukhsana A. Treatment of acute guttate psoriasis with rifampicin. Indian J Dermatol Venereol Leprol 2000; 66: 296-298.  Back to cited text no. 1    
2.Lockwood DNJ and Bryceson ADM. Leprosy In: Champion RH, Burton JL. Burns DA and Breathnach SM eds. Rook/ Wilkinson/ Ebling Textbook of Dermatology. 6th ed, Blackwell Science Ltd 1998: 1215-1235.  Back to cited text no. 2    
3.Bisno AL and Stevens DL. Streptococcal infections of skin and soft tissues. N Engl J Med 1996; 334: 240-245.  Back to cited text no. 3    
4.Chemotherapy of tuberculosis In: Satoskar RS and Bhandarkar SD, eds. Pharmacology and Pharmacotherapeutics. 9th ed, Bombay: Popular Prakashan 1985; 590-605.  Back to cited text no. 4    

 

Top
Print this article  Email this article
Previous article Next article

    

Online since 15th March '04
Published by Wolters Kluwer - Medknow